EYPT

EYPT

USD

EyePoint Pharmaceuticals Inc. Common Stock

$12.390+0.260 (2.143%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$12.130

Máximo

$12.950

Mínimo

$11.960

Volumen

4.59M

Fundamentos de la Empresa

Capitalización de Mercado

1.0B

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

1.08M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $3.91Actual $12.390Máximo $14.91

Noticias Relacionadas

GlobeNewswire

EyePoint Announces Pricing of Public Offering

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with

Ver más
EyePoint Announces Pricing of Public Offering
GlobeNewswire

EyePoint Announces Proposed Public Offering of Common Stock

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with

Ver más
EyePoint Announces Proposed Public Offering of Common Stock
GlobeNewswire

EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema

– DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New preclinical data

Ver más
EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.